Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_1382_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
11 Мб
Скачать
☆
Table 20.1. Development and evolution of surgical treatment of primary hyperparathyroidism
Unilateral neck
Development Bilateral neck exploration
1920s
1930s
1940–60s
1970s
1980s
1990s
2000s
NIH: National Institute of Health
Mandl F: First successful
operation in Austria.
Mandl F: Recurrence of
the first case
Cope O: Successful
removal of a adenoma in the mediastinum after several failed neck explorations
Ultrasonography
Computerized
tomography
A density test of resected
tissue
High-resolution
ultrasonography
201
99m
Tl-
Tc subtraction
scan
oil-red-O staining of
frozen sections
NIH Consensus for
asymptomatic cases
99m
Tc-sestamibi scan
intraoperative quick PTH
measurement
Prospective studies of
unilateral neck exploration
Randomized controlled
trials of bilateral versus unilateral or focused neck exploration
Walton AJ: ‘‘always exposure all
the parathyroid glands, sometimes search behind the trachea and the mediastinum’’
Kaplan EL: ‘‘strongly recommend
a bilateral exploration for all patients’’
Proye CAG: ‘‘routine bilateral
neck exploration is recommended’’
exploration
Wang CA: ‘‘only if an
adenoma is found on the first side and the other gland is normal’’
Tibblin S: ‘‘it is not
necessary to explore all four glands’’
Russell DFJ: ‘‘scan-
directed unilateral neck exploration is a legitimate alternative’’
280
ENDOCRINE SURGERY
Focused parathyroidectomy
Irvin GL: limited
parathyroidectomy guided by intraoperative quick PTH measurement
Gagner M: endoscopic
parathyroidectomy
especially when excessive biopsies of normal glands were performed [12]. In the survey by Tibblin, surgeons were rather conservative in intraoperative evaluation of normal-sized parathyroid glands, and only nine respondents performed the classical procedure among 43 surgical departments where bilateral neck
exploration was routinely performed [10] (Table 20.2). Thus it is important to note that what ‘‘bilateral neck exploration’’ means may differ among endocrine surgeons with regard to the extent of intraoperative evalua­tion techniques and the use of preoperative localization tests.
281
PARATHYROID
Table 20.2. Questionnaire survey on surgical procedures for primary hyperpar-
athyroidism due to single parathyroid adenoma reported in 1991 Neck exploration Biopsy of normally appeared glands Respondents Bilateral Excisional biopsy of one gland 7 (13%)
Incisional biopsy of three glands 9 (17%) Incisional biopsy of one to two glands 16 (31%) No biopsy 11 (21%)
Unilateral Excisional biopsy 6 (12%)
Incisional biopsy 3 (6%)
52 (100%)
Source: Data from [10].
Bilateral Versus Unilateral Neck Exploration: The Evidence
Systematic Review
Reeve et al. conducted a systematic review of the literature to compare the outcomes of mini­mally invasive surgery (either unilateral or focused) with those of bilateral neck exploration [13]. The authors, however, faced difficulty in drawing solid conclusions for the efficacy and safety of minimally invasive surgery because the selected studies differed in study designs, study populations, preoperative localization tests, surgical interventions, and outcomes [13–22] (Table 20.3).
Prospective, Quasi-Experimental Studies
Based on a prospective, multicenter study where five different surgical regimens for patients with primary hyperparathyroidism due to solitary adenoma were compared, Tibblin and his colleagues found that severe postoperative hypocalcemia was significantly more common after bilateral than unilateral exploration [23] (Table 20.4). They also concluded that unilateral parathyroidectomy without contralateral inspec­tion were no more likely to cause persistent or recurrent hypercalcemia than bilateral approach, given the diagnosis of single gland disease was confirmed by the use of intraoperative
fat staining. Other five prospective studies on unilateral neck exploration (not focused approaches) are summarized in Table 20.5. Russell and his colleagues pioneered in adopting the scan-directed unilateral neck exploration where contralateral side was also explored if preoperative or the unilateral approach failed to identify the parathyroid lesion [24]. Of the 90 patients in the study, 48 (53%) had unilateral surgery while the rest actually needed bilateral exploration. Among 46 patients with unilateral approach whose data were available at mean follow-up of
16.8 months, no one demonstrated persistent or recurrent hypercalcemia. Since hypercalcemia did not resolve in 6 of 42 individuals undergoing bilateral exploration, the overall success rate of this strategy was 93%. Later, the investigators retrospectively reviewed the long-term outcome of 184 patients in whom cervical exploration was limited to one side [25]. Following the initial operation three patients (1.6%) demonstrated persistent hypercalcemia while none of the cured patients had developed recurrent disease at mean follow-upof59months.WeiandBurkeexamined if preoperative radiologic localization with unilat­eral neck exploration reduced operative time compared with full bilateral neck exploration. They observed that unilateral neck exploration provided 100% cure and would save approxi­mately 30 min in completing curative surgery [21]. Norman et al. also reported 100% cure rate of unilateral neck exploration with a study population of primary hyperparathyroidism patients with a solitary adenoma detected by pre­operative
201
99m
Tl-
Tc scanning was negative
99m
Tc sestamibi scanning [17]. Carty
ENDOCRINE SURGERY
Table 20.3. Studies included in the systematic review of unilateral and bilateral neck exploration for primary
hyperparathyroidism Author Study design Study population Preoperative imaging Intervention Outcomes Vogel [14] Retrospective 106 PHPT US (93), MIBI (17) UNE > BNE IS, OT, OS, AE Denham [15] ‘‘meta-
analysis’’
Ryan [16] ‘‘Case-
100 sporadic PHPT US (93), Tl-Tc (84) UNE versus BNE IS, OT, OS, AE
control’’
Norman [17] Prospective
(with
historical
18 PHPT with MIBI positive (25 PHPT as historical
controls)
MIBI (18) vs no tests
(25)
UNE versus BNE IL, OT, HS,
controls) Vroonhoven [18] Prospective 66 PHPT US and CT Minimal > BNE OT, OS, AE Tsukamoto [19] Not declared. 160 PHPT Tl-Tc UNE > BNE IS, OT, OS Petti [20] Retrospective 100 PHPT Tl-Tc (50) vs. no tests
UNE versus BNE OT, OS, AE, C,
(50)
Wei [21] Prospective 33 PHPT with MIBI positive
indicating a solitary adenoma.
MIBI UNE +
contralateral neck exploration
Worsey [22] Retrospective 371 sporadic PHPT US (22), Tl-Tc (24),
UNE > BNE OS, OT, AE both (29), no tests (275)
PHPT: primary hyperparathyroidism, MIBI: tomography, UNE: unilateral neck exploration, BNE: bilateral neck exploration, UNE > BNE: unilateral neck exploration followed by contralateral exploration if no enlarged parathyroid glands were identified on the first side, IS: imaging success, OT: operative time, OS: operative success, C: cost, HS: hospital stay, AE: adverse event, IL: incision length, P: pathology. Source: Data from [13].
99m
Tc-sestamibi scan, Tl-Tc:
201
99m
Tl-
Tc subtraction scan, US: ultrasonography, CT: computed
Performance
of MIBI
OT, C, P
OS, AE
HS
OT
282
Table 20.4. Prospective multicenter study comparing five surgical regimens for primary hyperparathyroidism
Outcome hypercalcemia/
Study population 325 patients undergoing
initial Surgery for primary hyperparathyroidism due to solitary adenoma
Preoperative imaging
not described. 1. Unilateral PTX after UNE (50)
Intervention (number of available patients at follow-up)
2. Unilateral PTX after BNE (44)
3. BNE with removal of the enlarged gland and incisional biopsy of 1–2 normal-sized glands (84)
4. BNE with removal of the enlarged gland and
normocalcemia/ hypocalcemia (%)
2/96/2% 3/90/7% 11/80/9%
3/92/5%
incisional biopsy of 3 normal-sized glands (37)
5. BNE with removal of the enlarged gland but no
0/98/2%
biopsy (57)
PTX: parathyroidectomy, UNE: unilateral neck exploration, BNE: bilateral neck exploration. Source: Data from [23].
283
PARATHYROID
Table 20.5. Prospective, quasi-experimental studies of unilateral neck exploration
Study
Author
population
Russell [24] 90 PHPT
Norman
[17]
18 PHPT with a
single adenoma
Wei [21] 33 sporadic
PHPT with a solitary adenoma
Carty [26] 128 sporadic
PHPT
Moore [27] 48 sporadic
PHPT
PHPT: primary hyperparathyroidism, UNE: unilateral neck exploration, BNE: bilateral neck exploration, io-PTH: intraoperative PTH assay, US: ultrasonography. Note: Studies with minimally invasive (focused) surgery were excluded.
Preoperative imaging Intervention Results
201
99m
Tl-
Tc scan Scan-directed UNE (n = 48)
Removal of adenoma and biopsy of
the ipsilateral normal gland
Conversion to BNE if necessary
BNE when the scan negative or UNE
failed (n = 42)
Identification of all four
parathyroids
Removal of obviously enlarged
UNE/BNE = 48/42 Cure rate 100% in the UNE
patients at mean follow-up of 16.8 months (n = 46)
Persistent hypercalcemia
14% who needed BNE (6/42)
glands and biopsy of one normal-
99m
Tc sestamibi
scan
sized gland
UNE
Removal and frozen section of an
enlarged gland and search of a
UNE/BNE = 18/0 Cure rate: 100% (18/18) at 6
months after surgery
normal ipsilateral gland
99m
Tc sestamibi
scan
Conversion to BNE if necessary
UNE followed by contralateral
exploration
Removal of an enlarged gland and
Cure rate: 100% (33/33) UNE would save
approximately 30 min search and biopsy of a normal ipsilateral gland
Additional exploration and biopsy
of contralateral glands
Limited to high-
risk patients in Strategy A; routine in Strategy B.
Strategy A (n = 61)
Palpation method for selective UNE
Conversion to BNE if necessary
Strategy B (n = 67)
Routine use of both 99mTc
sestamibi SPECT and ioPTH
Removal of an enlarged gland and
search and biopsy of a normal
Strategy A UNE/BNE = 25/36
Cure rate at 6 months: 95%
(58/61)
Strategy B UNE/BNE = 42/25 Cure rate at 6 months: 99%
(66/67) ipsilateral gland
99m
Tc sestamibi scan, US if the scan failed.
Conversion to BNE if necessary
UNE when the scan/US indicated a
single disease, or both failed localization
Removal of adenoma and biopsy of
an ipsilateral normal gland
Use of io-PTH
Use of a handheld scintillation
UNE 32 (67%) UNE >> BNE 13 (27%) BNE 3 (6%) Cure rate 98% (47/48) at 3
months after surgery
detector when an adenoma could not be found on the predicted side
Conversion to BNE if necessary
BNE when the scan indicated bilateral
disease
284
ENDOCRINE SURGERY
et al. compared two surgical approaches to concise parathyroidectomy. Routine use of preo­perative
99m
Tc sestamibi single photon emission computed tomography and intraoperative quick PTH measurement was associated with significant reductions in extent of surgery (i.e., more unilat­eral neck exploration) and the cure rate of 99%
unilateral neck exploration directed by preopera­tive localization techniques could be successful in around 60–70% of patients with seemingly sporadic primary hyperparathyroidism, and that cure rate can achieve over 95% given the contral­ateral side be explored if necessary and/orwith the
use of intraoperative quick PTH measurement. [26]. Moore and others examined the efficacy of unilateral neck exploration with the aid of preoperative localization modalities and intrao­perative PTH measurements. Unilateral neck
Experimental Studies (Randomized
Controlled Trials)
exploration was planned when the preoperative imaging studies indicated a single gland disease although bilateral search was made as needed. Thirty-two of the 48 patients (67%) had successful unilateral exploration while 16 patients ultimately underwent bilateral operation.Actualcurerateof this approach was 98% at 3 months after surgery [27]. These prospective studies suggested that
Table 20.6. Randomized controlled trial comparing unilateral (including focused parathyroidectomy) and bilateral neck
explorations for primary hyperparathyroidism
Study population Intervention Outcomes
Miccoli [28] 38 sporadic
PHPT suitable for VAP (i.e., ultra­sonography indicates a solitary adenoma)
Bergenfelz [29]
Westerdahl [30]
91 sporadic PHPT UNE group (n = 47):
VAP group (n = 20) :
Focused removal of an
adenoma
Use of io-PTH
Conversion to BNE if
necessary
BNE group (n = 18) :
Identify four glands
Removal and frozen section
of an enlarged gland
No biopsy of normal sized
gland
No io-PTH
Preoperative MIBI scan
Focused removal of an
adenoma
Use of io-PTH
Conversion to BNE if UNE
failed to make sure cure
BNE group (n = 44):
No localization studies
Identify four glands
Removal and frozen section
of an enlarged gland
No biopsy of normal sized
gland
No io-PTH
To date four randomized controlled trials com-
paring unilateral neck exploration with bilateral
approach have been published; yet, it should be
noted that the experiments differed in terms of
study populations, interventions, and outcome
measures [28–32]. (Table 20.6). In particular,
three of them utilized focused removal of an
Conversion to BNE in VAP group: 1/20 (5%) Cure rate:
19/19 (100%) in VAP group 17/17 (100%) in BNE group *1/20 (5%) in VAP group and 1/18 (6%) in BNE
group were excluded from the analysis because they were found to have multi-glandular disease
Conversion to BNE in the UNE group: 18/47 (38%) Cure rate at 6 weeks after surgery: 45/47 (96%) in UNE group
43/44 (98%) in BNE group Recurrence rate at 5 years after surgery: 2/38 (5%) in UNE group 1/33 (3%) in BNE group Overall 6 patients have found to have persistent (3)
or recurrent (3) primary hyperparathyroidism. Three of the 6 patients have found to have multiple endocrine neoplasia mutations
285
PARATHYROID
Table 20.6. (continued)
Study population Intervention Outcomes
Bergenfelz [31] 50 PHPT with a
solitary adenoma localized by
99m
Tc sestamibi
scan.
Russell [32] 100 PHPT whose
single tumor was identified at operation at the site suggested by the preoperative dual-isotope subtraction scanning using
99m
Tc and Tc­labeled sestamibi
PHPT: primary hyperparathyroidism, VAP: video-assisted parathyroidectomy, MIP: minimally invasive parathyroidectomy, BNE: bilateral neck exploration, UNE: unilateral neck exploration, io-PTH: intraoperative quick PTH measurement.
MIP ( n = 25)
Targeted resection of
adenoma
Io-PTH
Frozen-section analysis
Local anesthesia
Conversion to BNE if
necessary
BNE (n = 25)
Identify all four parathyroid
glands
Excision of enlarged glands
Frozen-section analysis
No io-PTH
General anesthesia
Scan-directed UNE (n = 54)
Removal of adenoma and
identification of the ipsilateral normal gland
No io-PTH
BNE (n = 46)
Identify the two
parathyroids on the contra-lateral side
Removal of obviously
enlarged glands
No io-PTH
Conversion to BNE in the MIP group: 3/25 (12%) Cure rate at 1 and 6 months
MIP: 24/25 BNE: 25/25
Cure rate at a mean of 23 months’ follow-up. UNE: 54/54 BNE: 46/46
adenoma rather than total unilateral exploration. Miccoli et al. compared video-assisted parathyr­oidectomy (VAP) against conventional bilateral neck exploration (bilateral neck exploration) with a study population consisting of 38 patients with sporadic primary hyperparathyroidism suitable for VAP (i.e., ultrasonography indicated a solitary parathyroid adenoma). Cure rates were 100% in both groups while the VAP group experienced less costs, shorter operative times, less pain, and better cosmetic results than the bilateral neck
exploration group [28]. Bergenfelz and others allocated either unilateral neck exploration or bilateral neck exploration to 91 patients with see­mingly sporadic primary hyperparathyroidism. Patients in the unilateral neck-exploration group underwent both preoperative
99m
Tc sestamibi scan and intraoperative monitoring of serum PTH whereas those in the bilateral neck-exploration group had neither localization studies nor intrao­perative PTH measurement. In the unilateral group, no attempts were made to visualize normal
286
ENDOCRINE SURGERY
parathyroid glands. Cure rates, operative time, cost, and postoperative pain were similar between the two groups [29]. Results of 5-year follow-up of the trial have recently been reported by Westerdahl and Bergenfelz. In addition to three persistent cases, three patients experienced disease recur­rence, two in the unilateral neck exploration group, and one in the bilateral neck exploration group on the intention-to-treat analysis despite the fact that five of them actually underwent bilateral neck exploration [30]. A trial in Germany randomized 50 patients with primary hyperparathyroidism with a solitary adenoma demonstrated by sestamibi scintigraphy to either MIP under local anesthesia or bilateral neck exploration under general anesthesia. Cure rates by the primary surgery were 96% in the MIP group and 100% in the bilateral exploration group, respectively [31]. Russell et al. compared scan-directed unilateral neck exploration with bilateral one. In this trial, 100 patients were randomized to one of the interventions during the surgery if a single adenoma was identified at the site suggested by the preoperative scintigraphy. All patients were cured in both groups [32]. Noninferiority, or even advantages, of unilateral neck explora­tion or focused parathyroidectomy have been demonstrated through these randomized con­trolled trials.
Bilateral Versus Unilateral Neck Exploration: In Practice
Evidence demonstrated that unilateral neck exploration or focused surgery with adequate preoperative imaging procedures and intrao­perative quick PTH measurement have, on aver- age, equivalent cure rate and even less invasive when compared with the use of bilateral neck exploration in treating primary hyperparathyr­oidism. On an individual basis, however, select- ing a particular surgical approach depends on various factors. In addition to the expertise of surgeons and the validity of preoperative loca­lization studies available, the success of the limited approach is highly dependent on the possibility of multiple gland disease of the indi­vidual [33].
Possibility of Multiglandular Disease – Prevalence
The prevalence of multiglandular disease in pri­mary hyperparathyroidism had been estimated to be around 15% [29]. In 1996, Moliani et al. found the figure to be 5% in their prospective study where 110 patients with seemingly spora­dic primary hyperparathyroidism underwent focused parathyroidectomy using quick intrao­perative PTH measurement [34]. Lee and Nor­ton reviewed their 214 consecutive patients who underwent bilateral neck exploration and found that 44 (20.6%) had multiglandular disease, although they did not indicate whether they excluded patients with multiple endocrine neo­plasia from the study population [35]. In the same article, the authors conducted a literature review to determine the prevalence of single adenoma and multiglandular disease in pub­lished studies of unilateral and bilateral neck exploration for primary hyperparathyroidism. Retrieved articles were grouped according to operative technique irrespective of study design and study population. Of 2,166 patients in 14 studies who underwent bilateral neck explora­tion, 19.3% had multiglandular disease, whereas the prevalence was found to be 5.3% among 2,095 patients from 31 published reports adopt­ing a focused unilateral approach [35]. As the authors cited, the observed difference in the prevalence can be explained in some ways. First, selection bias may play a role in assem­bling study populations. Patients whose preo­perative localization studies indicated multi­glandular disease were less likely to be candidates for unilateral or even focused opera­tions. Second, the definition of multiglandular disease could be different among selected stu­dies, namely functional versus morphological [29]. Thus studies with unilateral exploration might underestimate the prevalence while those with bilateral approach might overesti­mate the figure. Prevalence data of multi­glandular disease from four prospective stu­dies and four randomized trials cited in the previous sections were summarized in
Table 20.7. Although exact histopathological
diagnoses of multiglandular disease were not described in three randomized trials, the overall prevalence ranged from 0 to 15%. It should be noted that the confidence intervals
287
PARATHYROID
Table 20.7. Prevalence of multiglandular disease observed in prospective studies
Definition of multiple gland
Author Study design Russel [24] Prospective, quasi-
experimental
Wei [21] Prospective, quasi-
experimental
Carty [26] Prospective, quasi-
experimental
Moore [27] Prospective, quasi-
experimental
Miccoli [28] Randomized controlled
trial
Bergenfelz [29]
Westerdahl [30]
Bergenfelz [31] Randomized controlled
Russell [32] Randomized controlled
VAP: video-assisted parathyroidectomy, MIP: minimally invasive parathyroidectomy, BNE: bilateral neck exploration, UNE: unilateral neck exploration, io-PTH: intraoperative quick PTH measurement.
Randomized controlled
trial
trial
trial
disease Not described Hyperplasia 7% (3/42 underwent
Not described 0% (0/33 underwent BNE)
Not described. Hyperplasia 9% (11/128)
Not described. Hyperplasia 2% (1/48)
Morphological (BNE) and
functional (VAP)
UNE group: functional and
histopathology
BNE group: histopathology MIP group: functional and
histopathology
BNE group: histopathology Histological 0% (0/54) in UNE group
Prevalence of multiple gland disease
BNE)
Double adenomas 4% (5/128)
Double adenomas 13% (6/48) 5% (1/20) in VAP group
6% (1/18) in BNE group Overall 5% (2/38). 13% (6/47) in UNE group
11% (5/44) in BNE group Overall 12% (11/91) 4% (1/25) in MIP group 8% (2/25) in BNE group Overall 6% (3/50).
7% (3/46) in BNE group (Double
adenomas)
Overall 3% (3/100)
of the figures should be fairly large because the numbers of patients in each study were relatively small.
Possibility of Multiglandular Disease – Clinical Characteristics
One of the important clinicians’ jobs is to char­acterize a patient so that tests and interventions can fit her or his best outcomes. In fact, the ultimate goal of clinical epidemiology is to con­tribute this through thoughtful use of available evidence. Kebebew et al. developed a scoring model with data of preoperative clinical, bio­chemical, and imaging studies to differentiate patients with single from multiple gland disease by reviewing medical record of 238 consecutive patients with primary hyperparathyroidism including multiple endocrine neoplasia as well as persistent or recurrent diseases [36]. Their CaPTHUS dichotomous scoring model
consisted of five variables: (1) preoperative total calcium level 3 mmol/l (12 mg/dl); (2) intact PTH level 2 times the upper limit of normal PTH levels; (3) sestamibi scan results positive for one enlarged parathyroid gland; (4) neck ultrasound results positive for one enlarged parathyroid gland; and (5) concordant sestamibi and neck ultrasound study results (identifying one enlarged gland on the same side of the neck). A total score of 3 or greater had a sensitivity of 44% and specificity of 100% in predicting single-gland disease. Since there were no false positives, the authors concluded that patients with a score of 3 or higher could undergo an MIP without the routine use of intraoperative PTH or additional imaging studies. The model, however, remains to be validated because it was derived from a retro­spective analysis. In fact, even before develop­ing the model, the authors were successful in curing 99.2% of their patients in which 65% underwent unilateral or focused neck
288
ENDOCRINE SURGERY
Table 20.8. Conditions when bilateral neck exploration needs to be considered
Family history
p p p
Biochemical data
Localization studies
p p
p p
p p
Intraoperative findings at UNE
UNE: unilateral neck exploration.
p p
explorations. Although such a quantitative model can be useful, it may be more practical to consider each characteristic associated with multiglandular disease in individualizing the decision as to whether the neck should be explored bilaterally or not (Table 20.8).
Conclusions
There is no doubt that bilateral neck explora­tion has been the gold standard as the surgical procedure for primary hyperparathyroidism [37]. With the advent of modern medical tech­nologies, however, limited or focused approaches have become suitable alternatives for selected patients as the history has wit­nessed. An endocrine surgeon should use her or his expertise with deep understandings of the disease so that best outcomes are available for each patient.
References
1. Welbourn RB. The parathyroid glands. In: Welbourn RB. The history of endocrine surgery. New York: Prager Publications, 1990;217–236.
2. Cope O. The story of hyperparathyroidism at the Massachusetts General Hospital. N Engl J Med. 1966;271:1174–1182.
3. Walton AJ. The surgical treatment of parathyroid tumors. Br J Surg. 1931;19:285–291.
4. Wang CA, Rieder SV. A density test for the intraopera­tive differentiation of parathyroid hyperplasia from neoplasia. Ann Surg. 1978;187:63–67.
Primary hyperparathyroidism Urolithiasis Multiple endocrine neoplasia
Mild hypercalcemia Mild elevation of PTH
Negative Equivocal
Suggesting multiple gland disease Discordant results among several studies No adenoma Two enlarged glands
5. Tibblin S, Bondeson AG, Bondeson L, et al. Surgical strategy in hyperparathyroidism due to solitary ade­noma. Ann Surg. 1984;200:776–784.
6. Irvin GL, Dembrow VD, Prudhomme DL. Operative monitoring of parathyroid gland hyperfunction. Am J Surg. 1991;162:299–302.
7. Gagner M. Endoscopic subtotal parathyroidectomy in patients with primary hyperparathyroidism [letter]. Br J Surg. 1996;83:875.
8. Kaplan EL, Yashiro T, Salti G. Primary hyperparathyr­oidism in the 1990s: Choice of surgical procedures for this disease. Ann Surg. 1992;215:300–317.
9. Proye CAG, Carnaille B, Bizard JP, et al. Multiglandular disease in seemingly sporadic primary hyperparathyr­oidism revisited: Where are wein the early 1990s? A plea against unilateral parathyroid exploration. Surgery. 1992;112:1118–1122.
10. Tibblin S, Bondeson AG, Uden P. Current trends in the surgical treatment of solitary parathyroid adenoma: A questionnaire study from 53 surgical departments in 14 countries. Eur J Surg. 1991;157:103–107.
11. Sackett WR, Barraclough B, Reeve TS, et al. Worldwide trends in the surgical treatment of primary hyperpar­athyroidism in the era of minimally invasive parathyr­oidectomy. Arch Surg. 2002;137:1055–1059.
12. Kaplan EL, Barlett S, Sugimoto J, et al. Relation of post­operative hypocalcemia to operative techniques: Dele­terious effect of excessive use of parathyroid biopsy. Surgery. 1982;92:827–834.
13. Reeve TS, Babidge WJ, Parkyn RF, et al. Minimally invasive surgery for primary hyperparathyroidism: Sys­tematic review. Arch Surg. 2000;135:481–487.
14. Vogel LM, Lucas R, Czako P. Unilateral neck explora­tion. Am Surg. 1998;64:693–697.
15. Denham DW, Norman J. Cost-effectiveness of pre-operative sestamibi scan for primary hyperparathyroidism is depen­dent solely upon the surgeon’s choice of operative proce­dure. J Am Coll Surg. 1998;186:293–304.
16. Ryan JA, Eisenberg B, Pado KM, et al. Efficacy of selective unilateral exploration in hyperparathyroidism based on localization tests. Arch Surg. 1997;132:886–891.
17. Norman J, Chheda H, Farrell C. Minimally invasive para­thyroidectomy for primary hyperparathyroidism:
289
PARATHYROID
Decreasing operative time and potential complications while improving cosmetic results. Am Surg. 1998;64:391–396.
18. van Vroonhoven TJMV, van Dalen A. Successful mini­mally invasive surgery in primary hyperparathyroidism after combined preoperative ultrasound and computed tomography imaging. J Int Med. 1998;243:581–587.
19. Tsukamoto E, Russell CFJ, Ferguson WR, et al. The role of pre-operative thallium-technetium subtraction scintigraphy in the surgical management of patients with solitary parathyroid adenoma. Clin Radiol. 1995;50:677–680.
20. Petti GH, Chonkich GD, Morgan JW. Unilateral para­thyroidectomy: The value of the localizing scan. J Oto­laryngol. 1993;22:307–310.
21. Wei JP, Burke GJ. Analysis of saving in operative time for primary hyperparathyroidism using localization with Technetium 99m sestamibi scan. Am J Surg. 1995;170:488–491.
22. Worsey MJ, Carty SE, Watson CG. Success of unilateral neck exploration for sporadic primary hyperparathyr­oidism. Surgery. 1993;114:1024–1030.
23. Tibblin S, Bizard JP, Bondeson AG, et al. Primary hyper­parathyroidism due to solitary adenoma: A comparative multicentre study of early and long term results of dif­ferent surgical regimens. Eur J Surg. 1991;157:511–515.
24. Russell CFJ, Laird JD, Ferguson R. Scan-directed uni­lateral cervical exploration for parathyroid adenoma: A legitimate approach? World J Surg. 1990;14:406–409.
25. Sidhu S, Neill AK, Russell CFJ. Long-term outcome of unilateral parathyroid exploration for primary hyperparathyroidism due to solitary adenoma. World J Surg. 2003;27:339–342.
26. Carty SE, Worsey MJ, Virji MA, et al. Concise parathyr­oidectomy: The impact of preoperative SPECT sestamibi scanning and intraoperative quick parathor­mone assay. Surgery. 1997;122:1107–1116.
27. Moore FD, Mannting F, Tanasijevic M. Intrinsic limitations to unilateral parathyroid exploration. Ann Surg. 1999;230:382–391.
99m
Tc
28. Miccoli P, Bendinelli C, Berti P, et al. Video-assisted versus conventional parathyroidectomy in primary hyperparathyroidism: A prospective randomized study. Surgery. 1999;126:1117–1122.
29. Bergenfelz A, Lindblom P, Tibblin S, et al. Unilateral versus bilateral neck exploration for primary hyperpar­athyroidism: A prospective randomized controlled trial. Ann Surg. 2002;236:543–551.
30. Westerdahl J, Bergenfelz A. Unilateral versus bilateral neck exploration for primary hyperparathyroidism: Five-year follow-up of a randomized controlled trial. Ann Surg. 2007;246:976–981.
31. Bergenfelz A, Kanngiesser V, Zielke A, et al. Conven­tional bilateral cervical exploration versus open minimally invasive parathyroidectomy under local anaesthesia for primary hyperparathyroidism. Br J Surg. 2005;92:190–197.
32. Russel CFJ, Dolan SJ, Laird JD. Randomized clinical trial comparing scan-directed unilateral versus bilateral cervical exploration for primary hyperpar­athyroidism due to solitary adenoma. Br J Surg. 2006;93:418–421.
33. Duh QY, Uden P, Clark OH. Unilateral neck exploration for primary hyperparathyroidism: Analysis of a contro­versy using a mathematical model. World J Surg. 1992;16:654–662.
34. Moliani AS, Irvin GL, Deriso GT, et al. Incidence of multiglandular disease in primaryhyperparathyroidism determined by parathyroid hormone secretion. Surgery. 1996;120:934–937.
35. Lee NC, Norton JA. Multiple-gland disease in primary hyperparathyroidism: A function of operative approach? Arch Surg. 2002;137:896–900.
36. Kebebew E, Hwang J, Reiff E, et al. Predictors of single­gland vs multigland parathyroid disease in primary hyperparathyroidism: A simple and accurate scoring model. Arch Surg. 2006;141:777–782.
37. Allendorf J, DiGorgi M, Spanknebel K, et al. 1112 consecutive bilateral neck explorations for primary hyperparathyroidism. World J Surg. 2007;31:2075–2080.